Formulation and Evaluation of Hybrid Polymer Films using Metformin as Model Drug

Authors

  • T. Swetha Department of Pharmaceutics, Gland Institute of Pharmaceutical Sciences, Telangana.
  • Taher Patel Department of Pharmaceutical Chemistry, Gland Institute of Pharmaceutical Sciences, Telangana.
  • Bhavani Shankar Department of Pharmaceutics, Gland Institute of Pharmaceutical Sciences, Telangana
  • Syed Ahmed Department of Pharmaceutics, Gland Institute of Pharmaceutical Sciences, Telangana
  • Dr. N. Siva Subramanian Department of Pharmaceutical Chemistry, Gland Institute of Pharmaceutical Sciences, Telangana.

DOI:

https://doi.org/10.37591/rrjodfdp.v5i1.87

Abstract

The present work was to formulate transdermal films which can produce a constant and prolonged release of drug using Chitosan and polyethylene oxide. In the present study high molecular weight Chitosan (300 K) and Polyethylene oxide (600 K) were used.initially, pre-formulation studies were performed to check the solubility of drug and polymers. A suitable method was developed for the estimation of absorption maxima of the drug by UV double beam spectrophotometer.Transdermal polymeric films of Metformin are formulated using different concentrations and proportions of polymers keeping the drug concentration constant. Nine formulations were prepared by varying concentrations and molecular weight of Chitosan and Polyethylene oxide. Evaluation tests were performed and invitro permeation studies were carried out for all the films using phosphate buffer pH 7. From invitro permeation studies, series 2 formulations showed better drug release compared to remaining films.

 

Keywords: Transdermal films, Metformin, chitosan, polyethylene oxide

 

Cite this Article

T. Swetha, Taher Patel, Bhavani Shankar et al. Formulation and Evaluation of Hybrid Polymer Films Using Metformin as Model Drug. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2018; 5(1): 1–15p.

Downloads

Published

2018-07-16

Issue

Vol. 5 No. 1 (2018)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.